BioPoly® Granted an International Patent for Its Implant Technology
FORT WAYNE, IN – BioPoly LLC has announced that the Company has further expanded its intellectual property portfolio. The Company was granted another international patent for its partial resurfacing implants which protects the innovative implant designs. In addition to patents that cover the design of its implants, several U.S. and international patents have also been granted that address the Company’s unique BioPoly® material. The Company’s IP portfolio, including this most recent patent, provides assurance that all aspects of its implants, material, and surgical technique are protected throughout the world.
Rather than replacing the entire joint, the novel BioPoly® resurfacing implants are designed to replace only the damaged cartilage of a patient’s joint. The BioPoly® material used in the implants is a proprietary combination of hyaluronic acid and ultra-high molecular weight polyethylene, creating a self-lubricating polymer with enhanced wear properties. Implanted through simple, reproducible minimally invasive surgical techniques, BioPoly implants allow patients to quickly return to active, pain-free lifestyles, as shown by over eight years of clinical experience. The current BioPoly product offering consists of the RS Knee, RS Trochlea, RS Patella, and RS Shoulder implants. The implants are CE marked and currently available throughout Europe and in parts of Southeast Asia.
About BioPoly, LLC
BioPoly LLC is an ISO 13485 certified orthopaedic implant manufacturer located in Fort Wayne, Indiana. The Company is developing, manufacturing and marketing products for use in sports medicine and orthopaedics. Additional medical applications of the BioPoly® technology in cardiovascular, spinal, and trauma markets are also being pursued.
Additional information about BioPoly LLC and its partial joint resurfacing technology can be found on the BioPoly website.